Organogenesis
ORGO
$2.35
Share price
2.84%
Change (1 day)
14.63%
Change (1 year)
Categories
Organogenesis (ORGO) - Total debt
Total debt on the balance sheet as of December 2023 : $0.11 B
According to Organogenesis's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
Organogenesis - Total debt on balance sheet (from 2016 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -3.59% |
| 2022-12-31 | $0.12 B | -6.43% |
| 2021-12-31 | $0.13 B | 56.07% |
| 2020-12-31 | $84.77 M | -15.74% |
| 2019-12-31 | $0.10 B | 69.77% |
| 2018-12-31 | $59.26 M | -42.09% |
| 2017-12-31 | $0.10 B | |
| 2016-12-31 | $N/A | -100% |
| 2015-12-31 | $0.17 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.32 B | 173.62% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |